Risk management of onco-hematological drugs: How and how fast can we improve?

Mattia Altini, Marna Bernabini, Paolo Marchetti, Laura Orlando, Barbara Rebesco, Valeria Sirna

Research output: Contribution to journalArticle

Abstract

Purpose: Medication errors in oncology may cause severe damage to patients, professionals, and the environment. The Italian Ministry of Health issued Raccomandazione 14 to provide guidelines for prevention of errors while using antineoplastic drugs. This work aimed at analyzing Raccomandazione 14 through the different viewpoints of the hospital pharmacist, the nurse, the oncologist, and the hospital director. Methods: Twenty-seven Italian healthcare organizations participated in a self-assessment survey evaluating compliance with Raccomandazione 14 within the oncology, hematology, and pharmacy departments. Results: The self-assessment results showed a general acknowledgement of the need for centralized management of anticancer agents. The specific responsibility of the pharmacist on the centralized management of anticancer drugs from preparation to disposal emerged as a critical point. The nurse, beyond the skills in drug administration and prevention of extravasation, also plays a fundamental role in educating and supporting the patient. The physicians, who are attentive to scientific, clinical, and regulatory criteria in prescribing and monitoring the therapies, are called upon to improve awareness on the importance of sharing standardized procedures with other professionals, to minimize medication error occurrence. The implementation of a complete computerized management from prescribing to drug administration and follow-up was highlighted. Multidisciplinary groups were constituted across the nation by professionals dedicated to the implementation of electronic health records and drug history and medical reconciliation processes. Conclusions: Our analysis of the Ministerial Raccomandazione 14 urges implementation of the resources for ensuring quality and safety during prescription, preparation, and administration of anticancer drugs.

Original languageEnglish
Pages (from-to)S15-S29
JournalTumori
Volume102
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Risk Management
Medication Errors
Pharmacists
Antineoplastic Agents
Nurses
Pharmaceutical Preparations
Drug Prescriptions
Drug Compounding
Electronic Health Records
Hematology
Prescriptions
History
Organizations
Guidelines
Delivery of Health Care
Physicians
Safety
Health
Self-Assessment
Therapeutics

Keywords

  • Anticancer drugs
  • Hospital director
  • Nurse
  • Oncologist
  • Pharmacist
  • Risk management

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Risk management of onco-hematological drugs : How and how fast can we improve? / Altini, Mattia; Bernabini, Marna; Marchetti, Paolo; Orlando, Laura; Rebesco, Barbara; Sirna, Valeria.

In: Tumori, Vol. 102, 01.08.2016, p. S15-S29.

Research output: Contribution to journalArticle

Altini, Mattia ; Bernabini, Marna ; Marchetti, Paolo ; Orlando, Laura ; Rebesco, Barbara ; Sirna, Valeria. / Risk management of onco-hematological drugs : How and how fast can we improve?. In: Tumori. 2016 ; Vol. 102. pp. S15-S29.
@article{29a8a28ef8814059b54f39ceb8ec7fb8,
title = "Risk management of onco-hematological drugs: How and how fast can we improve?",
abstract = "Purpose: Medication errors in oncology may cause severe damage to patients, professionals, and the environment. The Italian Ministry of Health issued Raccomandazione 14 to provide guidelines for prevention of errors while using antineoplastic drugs. This work aimed at analyzing Raccomandazione 14 through the different viewpoints of the hospital pharmacist, the nurse, the oncologist, and the hospital director. Methods: Twenty-seven Italian healthcare organizations participated in a self-assessment survey evaluating compliance with Raccomandazione 14 within the oncology, hematology, and pharmacy departments. Results: The self-assessment results showed a general acknowledgement of the need for centralized management of anticancer agents. The specific responsibility of the pharmacist on the centralized management of anticancer drugs from preparation to disposal emerged as a critical point. The nurse, beyond the skills in drug administration and prevention of extravasation, also plays a fundamental role in educating and supporting the patient. The physicians, who are attentive to scientific, clinical, and regulatory criteria in prescribing and monitoring the therapies, are called upon to improve awareness on the importance of sharing standardized procedures with other professionals, to minimize medication error occurrence. The implementation of a complete computerized management from prescribing to drug administration and follow-up was highlighted. Multidisciplinary groups were constituted across the nation by professionals dedicated to the implementation of electronic health records and drug history and medical reconciliation processes. Conclusions: Our analysis of the Ministerial Raccomandazione 14 urges implementation of the resources for ensuring quality and safety during prescription, preparation, and administration of anticancer drugs.",
keywords = "Anticancer drugs, Hospital director, Nurse, Oncologist, Pharmacist, Risk management",
author = "Mattia Altini and Marna Bernabini and Paolo Marchetti and Laura Orlando and Barbara Rebesco and Valeria Sirna",
year = "2016",
month = "8",
day = "1",
doi = "10.5301/tj.5000540",
language = "English",
volume = "102",
pages = "S15--S29",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Risk management of onco-hematological drugs

T2 - How and how fast can we improve?

AU - Altini, Mattia

AU - Bernabini, Marna

AU - Marchetti, Paolo

AU - Orlando, Laura

AU - Rebesco, Barbara

AU - Sirna, Valeria

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Purpose: Medication errors in oncology may cause severe damage to patients, professionals, and the environment. The Italian Ministry of Health issued Raccomandazione 14 to provide guidelines for prevention of errors while using antineoplastic drugs. This work aimed at analyzing Raccomandazione 14 through the different viewpoints of the hospital pharmacist, the nurse, the oncologist, and the hospital director. Methods: Twenty-seven Italian healthcare organizations participated in a self-assessment survey evaluating compliance with Raccomandazione 14 within the oncology, hematology, and pharmacy departments. Results: The self-assessment results showed a general acknowledgement of the need for centralized management of anticancer agents. The specific responsibility of the pharmacist on the centralized management of anticancer drugs from preparation to disposal emerged as a critical point. The nurse, beyond the skills in drug administration and prevention of extravasation, also plays a fundamental role in educating and supporting the patient. The physicians, who are attentive to scientific, clinical, and regulatory criteria in prescribing and monitoring the therapies, are called upon to improve awareness on the importance of sharing standardized procedures with other professionals, to minimize medication error occurrence. The implementation of a complete computerized management from prescribing to drug administration and follow-up was highlighted. Multidisciplinary groups were constituted across the nation by professionals dedicated to the implementation of electronic health records and drug history and medical reconciliation processes. Conclusions: Our analysis of the Ministerial Raccomandazione 14 urges implementation of the resources for ensuring quality and safety during prescription, preparation, and administration of anticancer drugs.

AB - Purpose: Medication errors in oncology may cause severe damage to patients, professionals, and the environment. The Italian Ministry of Health issued Raccomandazione 14 to provide guidelines for prevention of errors while using antineoplastic drugs. This work aimed at analyzing Raccomandazione 14 through the different viewpoints of the hospital pharmacist, the nurse, the oncologist, and the hospital director. Methods: Twenty-seven Italian healthcare organizations participated in a self-assessment survey evaluating compliance with Raccomandazione 14 within the oncology, hematology, and pharmacy departments. Results: The self-assessment results showed a general acknowledgement of the need for centralized management of anticancer agents. The specific responsibility of the pharmacist on the centralized management of anticancer drugs from preparation to disposal emerged as a critical point. The nurse, beyond the skills in drug administration and prevention of extravasation, also plays a fundamental role in educating and supporting the patient. The physicians, who are attentive to scientific, clinical, and regulatory criteria in prescribing and monitoring the therapies, are called upon to improve awareness on the importance of sharing standardized procedures with other professionals, to minimize medication error occurrence. The implementation of a complete computerized management from prescribing to drug administration and follow-up was highlighted. Multidisciplinary groups were constituted across the nation by professionals dedicated to the implementation of electronic health records and drug history and medical reconciliation processes. Conclusions: Our analysis of the Ministerial Raccomandazione 14 urges implementation of the resources for ensuring quality and safety during prescription, preparation, and administration of anticancer drugs.

KW - Anticancer drugs

KW - Hospital director

KW - Nurse

KW - Oncologist

KW - Pharmacist

KW - Risk management

UR - http://www.scopus.com/inward/record.url?scp=84992365915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992365915&partnerID=8YFLogxK

U2 - 10.5301/tj.5000540

DO - 10.5301/tj.5000540

M3 - Article

VL - 102

SP - S15-S29

JO - Tumori

JF - Tumori

SN - 0300-8916

ER -